Avalo Therapeutics, Inc. · NASDAQ:AVTX

Affinity Asset Advisors, LLC reported a 5.30% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Dec 23, 2024 · Filed Dec 31, 2024

Affinity Asset Advisors, LLC reported a 5.30% stake in Avalo Therapeutics, Inc., 550,765 shares, as a passive investor on Dec 23, 2024. Filed Dec 31, 2024 (Schedule 13G).

Stake
5.30%
Shares
550,765
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Healthcare Fund, LP5.30%550,765
Affinity Asset Advisors, LLC5.30%550,765

Source

View original at SEC

Related